Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders

Journal of Neuroimmune Pharmacology

Volumn 2, Issue 1, 2007, Pages 8-13

  Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Anti inflammatory; Blood brain barrier; Microglia; P glycoprotein; Preclinical therapeutics

Indexed keywords

BIOLOGICAL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; DEGENERATIVE DISEASE; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFLAMMATION; METHODOLOGY; PATHOLOGY; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HIV-1; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES;

EID: 33846813904     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-006-9050-2     Document Type: Review

References (14)

1. Fox HS, Weed MR, Huitron-Resendiz S, Baig J, Horn TF, Dailey PJ, Bischofberger N, Henriksen SJ (2000) Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest 106:37-45
2. Giulian D (1999) Microglia and the immune pathology of Alzheimer's disease. Am J Hum Genet 65(1):13-18
3. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatrick JB (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27 (1):119-137
4. Horn TFW, Huitron-Resendiz S, Weed MR, Henriksen SJ, Fox HS (1998) Early physiological abnormalities after simian immunodeficiency virus infection. Proc Natl Acad Sci USA 95:15072-15077
5. Liang XJ, Aszalos A (2006) Multidrug transporters as drug targets. Curr Drug Targets 7(8):911-921
6. Marcondes MC, Burudi EM, Huitron-Resendiz S, Sanchez-Alavez M, Watry D, Zandonatti M, Henriksen SJ, Fox HS (2001) Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol 167:5429-5438
7. Marcondes MC, Phillipson CA, Fox HS (2003) Distinct clonal repertoire of brain CD8+ cells in simian immunodeficiency virus infection. AIDS 17:1605-1611
8. Prospero-Garcia O, Gold LH, Fox HS, Polis I, Koob GF, Bloom FE, Henriksen SJ (1996) Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc Natl Acad Sci USA 93:14158-14163
9. Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS (2003) Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol 162:2041-2057
10. Roberts ES, Masliah E, Fox HS (2004a) CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol 63:1255-1264
11. Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, Watry DD, Zandonatti MA, Taffe MA, Fox HS (2004b) Acute SIV infection of the brain leads to upregulation of IL6 and interferonr-egulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol 157:81-92
12. Roberts ES, Huitron-Resendiz S, Taffe MA, Marcondes MC, Flynn CT, Lanigan CM, Hammond JA, Head SR, Henriksen SJ, Fox HS (2006) Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. J Neurosci 26:4577-4585
13. von Herrath M, Oldstone MB, Fox HS (1995) Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 154:5582-5589
14. Weed MR, Gold LH, Polis I, Koob GF, Fox HS, Taffe MA (2004) Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection. AIDS Res Hum Retrovir 20:77-89